A phase II study of 131 I-MIBG for refractory neuroblastoma. Read more about A phase II study of 131 I-MIBG for refractory neuroblastoma.
PDGFR is activated through an autocrine mechanism in ovarian cancer. Read more about PDGFR is activated through an autocrine mechanism in ovarian cancer.
Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis. Read more about Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis.
Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis. Read more about Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis.
A phase II trial of interferon-alpha and celecoxib in metastatic renal carcinoma: clinical and anti-angiogenic effects. Read more about A phase II trial of interferon-alpha and celecoxib in metastatic renal carcinoma: clinical and anti-angiogenic effects.
A phase II trial of interferon-alpha and celecoxib in metastatic renal carcinoma: clinical and anti-angiogenic effects. Read more about A phase II trial of interferon-alpha and celecoxib in metastatic renal carcinoma: clinical and anti-angiogenic effects.
